Bioelectrix is pleased to announce the appointment of Jan Hörling as our new Chair of the Board. Jan joins Bioelectrix at an exciting time as we continue to strengthen our strategy, build momentum, and advance our mission to improve outcomes for patients with hard-to-heal wounds.
Jan brings extensive experience from the life science and medtech sectors, with senior leadership roles spanning R&D, marketing, and corporate strategy. He currently holds an executive position at Wellspect HealthCare, where he has served in roles including Vice President, Medical Affairs and Market Access. Jan has also held leadership positions at GE Healthcare and Biovitrum, building a strong track record at the intersection of clinical value, market adoption, and long-term growth.
Strengthening Bioelectrix’s path to market
At Bioelectrix, Jan will work closely with the team and the Board to support our growth, sharpen our strategic direction, and help accelerate our path to market for our bioelectrical wound dressing designed to support the treatment of hard-to-heal wounds through bioelectronic stimulation and real-time monitoring.
Already making a positive impact
Although Jan is newly appointed as Chair, he has already contributed strongly in his early engagement with Bioelectrix. His guidance has been valuable in strengthening discussions around strategic priorities, positioning, and the steps needed to scale in a complex healthcare environment. We’re excited to build on this momentum together.
Welcome, Jan!
We’re delighted to welcome Jan in his new role and look forward to what we will accomplish with his support and leadership.
Please join us in welcoming Jan Hörling to Bioelectrix! ⚡️⚡️